New Defense Minister Plans to increase exports of home-made defense products

Young journalists club

News ID: 53025
Iran » Iran
Publish Date: 17:51 - 28 August 2021
Saturday, 28 August 2021 (YJC)_ Iran’s new Defense Minister announced that he plans to increase exports of domestic defense products.

New Defense Minister Plans to increase exports of home-made defense productsDuring a meeting with former Defense Minister Brigadier General Amir Hatami, Iran’s new Defense Minister Brigadier General Mohammad Reza Ashtiani announced that he plans to enhance the country’s combat power and increase exports of domestic defense products.

“Improving combat capability by upgrading defense systems against possible hard- and semi-hard threats posed by enemies against the country will be our priority while we are going to increase exports of domestic defense products,” he said.

He thanked General Amir Hatami for measures taken over the past four years for materializing most objectives of Iran’s defense industry and said “The Ministry of Defense would Benefit from high capabilities of both public and private sectors.”

“Knowledge-based companies is of the other priorities that will be followed up strictly at,” he mentioned.

Elsewhere in his remarks, he announced that ‘Fakhra Vaccine’ has reached its final stages and would be mass-produced in the very near future while saying the production of coronavirus vaccine in the country as one of the main priorities.

Last week, Member of the Scientific Committee of Coronavirus Combat and Prevention Mostafa Qaneyee announced that the country is going to produce 3 new coronavirus vaccines next year.

Also Previously, Commander of the Islamic Revolution Guards Corps (IRGC) Major General Hossein Salami said that the home-made anti-coronavirus vaccine is ready to enter the second stage of clinical trial while he was visiting the inauguration of a 64-bed hospital for coronavirus patients in Kerman in Southeastern Iran.

“Noora vaccine is passing the necessary phases and will reach final stage in next few months,” he said while noting that “Our domestic vaccine, Noora, was successful in its first phase of clinical trial; now effective steps have been taken for entering the second phase of clinical trial.”

During a ceremony in June in the presence of General Salami, Iran’s Health Minister Saeed Namaki and other Iranian health officials the recombinant Noora vaccine, produced by Baqiyatallah University of Medical Sciences, was put on display.

Baqiyatallah University of Medical Sciences in Tehran works under the supervision of the IRGC. Noora vaccine reached the stage of the clinical trial after 16 months of research work by Iranian scientists.

Your Comment